REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mercury Pharmacy Sdn.Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Mercury Pharmacy Sdn.Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mercury Pharmacy Sdn.Bhd. is an enterprise based in Malaysia. Its main office is in Mentakab. It operates in the Pharmacies and Drug Stores industry. The company was established on February 28, 1985. Its’ total assets recorded a negative growth of 5.04%.

Headquarters
No.63, Jalan Temerloh
Mentakab; Pahang; Postal Code: 28400

Contact Details: Purchase the Mercury Pharmacy Sdn.Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mercury Pharmacy Sdn.Bhd. report to view the information.
Registered Capital:
Purchase the Mercury Pharmacy Sdn.Bhd. report to view the information.
Financial Auditors:
Purchase the Mercury Pharmacy Sdn.Bhd. report to view the information.
Incorporation Date:
February 28, 1985
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
6.67%
Purchase this report to view the information.
3.33%
Company Performance
Financial values in the chart are available after Mercury Pharmacy Sdn.Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
5.67%▲
EBITDA
36.44%▲
Net Profit (Loss) for the Period
29.58%▲
Total assets
-5.04%▼
Total equity
3.79%▲
Return on Equity (ROE)
0.72%▲
Debt to Equity Ratio
-7.45%▼
Quick Ratio
0.85%▲
Cash Ratio
0.05%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo